Dosing should be individualized
Perhaps most importantly, robust clinical evidence supporting strict discontinuation thresholds in CKD are currently lacking
The core of the lawsuit alleges that Novo Nordisk and Eli Lilly, the manufacturers of these drugs, failed to provide sufficient warnings about potential severe gastrointestinal side effects
Choosing the Right GLP-1 Weight Loss Solution: Liraglutide vs Semaglutide at En Vogue IV Therapy & Wellness What distinguishes Semaglutide GLP-1 from Liraglutide
Tirzepatide Programs (Zepbound & Mounjaro) For advanced weight management, tirzepatide targets both GLP-1 and GIP receptors for a dual-action effect on insulin sensitivity and deep fat loss
Owing to the recent increase in the prevalence of prediabetes, diabetes, obesity, and abdominal obesity among young adults under the age of 40 [1,7], there have been suggestions for a change in previous screening criteria for diabetes (adults aged 40 and adults aged 30 years with risk factors) [2]